Immatics N.V. (IMTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
IMTX currently has 84.7M outstanding shares. with limited dilution risk as only 2.42M additional shares (2.9%) are authorized for issuance. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 27, 2025 |
F-3 filing: Immatics N.V. files an F-3 form to register a shelf offering of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and units, with a total proposed amount of $500,000,000. |
85M | 2.4M |
| Mar 27, 2025 |
20-F filing | 121.6M shares outstanding |
120M | 2.4M |
| Mar 21, 2024 |
20-F filing | 84.7M shares outstanding |
85M | 2.4M |
| Aug 25, 2023 |
F-3 filing: This F-3 filing relates to the offer and sale from time to time by Bristol-Myers Squibb Company of up to 2,419,818 ordinary shares of Immatics N.V. The securities were issued to the selling securityholder on July 21, 2023, in a private placement transaction, and the company is registering the offer and sale of these securities to satisfy certain registration rights. |
77M | 2.4M |
| Mar 22, 2023 |
20-F filing | 76.7M shares outstanding |
77M | 0 |
| Mar 23, 2022 |
20-F filing | 62.9M shares outstanding |
63M | 0 |
| Aug 02, 2021 |
F-3 filing: Immatics N.V. files an F-3 form to register the offering of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and units, with a total proposed amount of up to $500,000,000. |
63M | 0 |
| Aug 02, 2021 |
POS AM filing: This is a POS AM filing relating to the offer and sale from time to time by the selling securityholders of up to 39,332,281 ordinary shares of IMMATICS N.V. |
63M | 0 |
| Mar 30, 2021 |
20-F filing | 62.9M shares outstanding |
63M | 0 |
| Mar 30, 2021 |
POS AM filing: This is a POS AM filing detailing the expenses associated with the offer and sale of ordinary shares by selling securityholders, including SEC registration fees, legal fees, accounting fees, and other miscellaneous expenses. |
63M | 0 |
| Jul 31, 2020 |
F-1 filing: This F-1 filing relates to the offering of ordinary shares by selling securityholders. The company will not receive any proceeds from the sales. |
63M | 39M |